This segment focuses on the development, manufacturing, and commercialization of branded generic pharmaceuticals and other healthcare products. Research and development activities include the formulation and testing of new drug products, as well as the improvement of existing formulations. Technologies and methodologies employed include advanced manufacturing processes, quality control systems, and regulatory compliance. The therapeutic areas covered are diverse, including dermatology, women's health, pain treatment, and ophthalmology, with key brands like Dekristol, Allergovit, and Tromcardin. The segment aims to improve patient outcomes by providing accessible and effective medications. Dermapharm's market positioning is strong in Germany and internationally, with a focus on off-patent drugs. Future opportunities lie in expanding the product portfolio and entering new markets. Regulatory and clinical aspects are crucial, with a focus on obtaining and maintaining necessary approvals. Partnerships and collaborations are essential for product development and market access.

This segment focuses on importing originator pharmaceuticals under the axicorp brand. The business model involves sourcing pharmaceuticals from various markets and importing them into Germany, taking advantage of price differences. This segment utilizes established supply chains and logistics networks to ensure efficient distribution. The therapeutic areas covered are broad, encompassing a wide range of conditions treated by originator drugs. The patient impact is primarily related to providing access to medications at potentially lower costs. Dermapharm's market positioning is based on its ability to efficiently manage the import and distribution of pharmaceuticals. Future opportunities include expanding the range of imported products and optimizing supply chain operations. Regulatory compliance is critical, requiring adherence to import regulations and quality standards. Partnerships with pharmaceutical manufacturers and distributors are essential for securing product supply and market access.

This segment specializes in the production and supply of herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. Research and development activities include the extraction and purification of active compounds from various plant sources, as well as the development of new formulations. Technologies and methodologies used include advanced extraction techniques, quality control, and standardization processes. The therapeutic areas or applications include phytopharmaceuticals, nutraceuticals, and cosmetic products. The patient impact is related to providing natural remedies and ingredients for health and wellness. Dermapharm's market positioning is based on its expertise in herbal extraction and its ability to supply high-quality ingredients. Future opportunities include expanding the range of extracts and ingredients, as well as developing new formulations. Regulatory and clinical aspects involve compliance with regulations for herbal products and ingredients. Partnerships with pharmaceutical, nutraceutical, and cosmetic companies are essential for product development and market access.